Author:
Cohen ,Galanello ,Piga ,DiPalma ,Vullo ,Tricta
Reference51 articles.
1. Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial;Agarwal;British Journal of Haematology,1992
2. Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major;Al-Refaie;Blood,1992
3. Agranulocytosis in a patient with thalassaemia major during treatment with the oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one;Al-Refaie;Acta Haematologica,1993
4. Deferiprone-associated myelotoxicity;Al-Refaie;European Journal of Haematology,1994a
5. Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one or desferrioxamine;Al-Refaie;Journal of Clinical Pathology,1994b
Cited by
132 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献